z-logo
open-access-imgOpen Access
An Interesting Case of Proteinuria: AL Amyloidosis
Author(s) -
Dipti Chand,
Rajesh V. Gosavi,
Anubhav Chakraborty,
Tejas Kungar,
Yash Paliwal
Publication year - 2022
Publication title -
vidarbha journal of internal medicine
Language(s) - English
Resource type - Journals
ISSN - 0976-4356
DOI - 10.25259/vjim_16_2021
Subject(s) - plasma cell dyscrasia , amyloidosis , medicine , al amyloidosis , proteinuria , dyscrasia , nephrotic syndrome , heart failure , cardiac amyloidosis , pathology , disease , dermatology , immunoglobulin light chain , plasma cell , multiple myeloma , immunology , kidney , antibody
Light-chain (AL) amyloidosis is the most common form of systemic amyloidosis and is associated with an underlying plasma cell dyscrasia. The disease often is difficult to recognise because of its broad range of manifestations and what often are vague symptoms. The clinical syndromes at presentation include nephrotic-range proteinuria with or without renal dysfunction, hepatomegaly, congestive heart failure and autonomic or sensory neuropathy. Recent diagnostic and prognostic advances include the serum free light-chain assay, cardiac magnetic resonance imaging and serologic cardiac biomarkers. Treatment strategies that have evolved during the past decade are prolonging survival and preserving organ function in patients with this disease. This review outlines approaches to diagnosis, assessment of disease severity and treatment of AL amyloidosis. We describe a case of a 54--year-old male patient with monoclonal gammopathy with AL amyloidosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom